hiv-aids

Documents about hiv-aids

• Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women#887809ClinicalTrials.gov
• IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults#911770ClinicalTrials.gov
• Perfil epidemiológico de portadores do HIV com manifestações estomatológicas em cinco centros de referência na cidade de Porto Alegre#935273Repositório PUCRS
• Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells#492118eScholarship
• A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection#853930ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection#881721ClinicalTrials.gov
• Address by Dr Mahmoud Fikri Regional Director WHO Eastern Mediterranean Region to the Middle East and North Africa Regional co-sponsors meeting, Cairo, Egypt, 11 April 2017#286823WHO IRIS
• Social and Genetic Networks of HIV-1 Transmission in New York City#491877eScholarship
• Poor Self-efficacy for Healthcare Provider Interactions Among Individuals with HIV-Associated Neurocognitive Disorders#784348eScholarship
• A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3#847624ClinicalTrials.gov
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole#869105ClinicalTrials.gov
• AIM-PrEP: AI-Agent Driven Multicenter Intervention to Improve PrEP Adherence and Health Monitoring Among Men Who Have Sex with Men (MSM)-Protocol of A Randomized Controlled Trial#337059bioRxiv / medRxiv
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma#843234ClinicalTrials.gov
• Phase II Motivational Interviewing: An Experiential Online Training Tool#857045ClinicalTrials.gov
• Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV‐infected women#609424eScholarship
• Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals#612078eScholarship
• A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV#849728ClinicalTrials.gov
• A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP#967547ClinicalTrials.gov
• Time to incidence of tuberculosis and its predictors among adult HIV/AIDS patients who initiated ART by the Universal Test and Treat approach in Silte Zone, Ethiopia, 2023.#2802NCBI PubMed Central
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS#143598ClinicalTrials.gov
• Dexamethasone in Cryptococcal Meningitis#899560ClinicalTrials.gov
• Vietnam Cryptococcal Retention in Care Study Version 1.0#900210ClinicalTrials.gov
• Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)#881922ClinicalTrials.gov
• Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection#642236eScholarship
• A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems#833728ClinicalTrials.gov
• Fluorescence Spectroscopy for Gut Permeability Assessment#862042ClinicalTrials.gov
• Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)#890971ClinicalTrials.gov
• A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine#1009225ClinicalTrials.gov
• SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages#619969eScholarship
• The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study#675962eScholarship
• Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial#620015eScholarship
• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy#861565ClinicalTrials.gov
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)#886799ClinicalTrials.gov
• Psychological Distress, Felt Stigma, and HIV Prevention in a National Probability Sample of Sexual Minority Men#620003eScholarship
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis#802649ClinicalTrials.gov
• The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS#838978ClinicalTrials.gov
• Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya#868300ClinicalTrials.gov
• Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use#994900ClinicalTrials.gov
• The Psychosocial Well-Being of Orphans in the Context of HIV/AIDS in Tanzania: - A Case of 13 to 15-Years-Old Orphans in Kihologota Ward, Iringa Rural District, Tanzania#1023018The Open University of Tanzania Institutional Repository
• A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59#868823ClinicalTrials.gov
• microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2#609464eScholarship
• 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada#620034eScholarship
• Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women#642151eScholarship
• The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients#1044247ClinicalTrials.gov
• Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.#329703Dipòsit Digital de la Universitat de Barcelona
• HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread#609389eScholarship
• Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection#609404eScholarship
• Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography#784379eScholarship
• Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies#491876eScholarship
• Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial#642077eScholarship